InheRET utilizes an online tool to collect detailed family health histories, enabling individuals to assess their genetic risk for hereditary cancers such as breast and colon cancer. By providing personalized risk reduction strategies, the platform empowers users to take proactive steps in disease prevention, addressing the critical issue of undetected hereditary conditions in millions of people.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ABFounders
Product
Problem
Many individuals are unaware of their increased risk for developing hereditary cancers due to a lack of comprehensive family health history assessment. This lack of awareness can lead to delayed detection and intervention, resulting in poorer outcomes for conditions like breast, colon, ovarian, and pancreatic cancer. Millions remain unaware of their genetic predispositions, missing opportunities for proactive risk management.
Solution
InheRET is an online platform designed to collect and analyze detailed family health histories, enabling individuals and healthcare providers to assess genetic risks for hereditary cancers. The platform uses best-practice guidelines to provide personalized risk reduction strategies tailored to individual risk levels. By identifying those at increased risk, InheRET empowers users to take proactive steps in disease prevention and facilitates timely interventions. The tool aims to streamline the risk assessment process, ensuring that all relevant hereditary cancer risks are considered, and appropriate next steps are taken.
Target Audience
The primary target audience includes individuals seeking to understand their risk for hereditary cancers, healthcare providers aiming to efficiently identify high-risk patients, and employers looking to offer preventative health benefits to their employees.
Features
- Online questionnaire for individuals to self-report detailed family health histories.
- Application of comprehensive guidelines to identify risks for a range of hereditary cancers, including breast, colon, ovarian, pancreatic, and prostate cancers.
- Personalized risk reduction strategies based on individual risk levels.
- Reporting tools for healthcare providers to facilitate appropriate interventions.
- Secure platform for data collection and analysis.